secwatch / observer
8-K filed Mar 27, 2025 23:59 UTC ticker ZSQR CIK 0001759186
leadership confidence high sentiment negative materiality 0.55

Coeptis CSO/CMO Colleen Delaney resigns effective March 24; will consult up to 6 months

Z Squared Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001683168-25-001940
form_type
8-K
ticker
ZSQR
cik
0001759186
company_name
Z Squared Inc.
filed_at
2025-03-27T23:59:59+00:00
discovered_at
2026-05-14T18:03:04.753090+00:00
generated_at
2026-05-24T04:00:06.266394+00:00
sec_items
["5.02"]
event_type
leadership
sentiment
negative
materiality_score
0.55
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001683168-25-001940
json_url
https://secwatch.observer/filing/0001683168-25-001940.json
markdown_url
https://secwatch.observer/filing/0001683168-25-001940.md
text_url
https://secwatch.observer/filing/0001683168-25-001940.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1759186/000168316825001940/0001683168-25-001940-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1759186/000168316825001940/coeptis_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Colleen Delaney

Chief Scientific and Medical Officer
ZSQR · Z Squared Inc.
Effective
2025-03-24
Filed
Mar 27, 2025 23:59 UTC
On March 21, 2025, Colleen Delaney submitted her resignation from her role as Chief Scientific and Medical Officer of the Coeptis Therapeutics Holdings, Inc. (the “Company”), effective March 24, 2025.

Source-grounded claims

ec5585a7ef

Colleen Delaney resigned as Chief Scientific and Medical Officer at Z Squared Inc..

On March 21, 2025, Colleen Delaney submitted her resignation from her role as Chief Scientific and Medical Officer of the Coeptis Therapeutics Holdings, Inc. (the “Company”), effective March 24, 2025.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Source: SEC EDGAR
accession 0001683168-25-001940

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.